Isabelle Laforest-Lapointe
Marie-Claire Arrieta- 1Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada
- 2Department of Pediatrics, University of Calgary, Calgary, AB, Canada
Alterations in gut microbial colonization during early life have been reported in infants that later developed asthma, allergies, type 1 diabetes, as well as in inflammatory bowel disease patients, previous to disease flares. Mechanistic studies in animal models have established that microbial alterations influence disease pathogenesis via changes in immune system maturation. Strong evidence points to the presence of a window of opportunity in early life, during which changes in gut microbial colonization can result in immune dysregulation that predisposes susceptible hosts to disease. Although the ecological patterns of microbial succession in the first year of life have been partly defined in specific human cohorts, the taxonomic and functional features, and diversity thresholds that characterize these microbial alterations are, for the most part, unknown. In this review, we summarize the most important links between the temporal mosaics of gut microbial colonization and the age-dependent immune functions that rely on them. We also highlight the importance of applying ecology theory to design studies that explore the interactions between this complex ecosystem and the host immune system. Focusing research efforts on understanding the importance of temporally structured patterns of diversity, keystone groups, and inter-kingdom microbial interactions for ecosystem functions has great potential to enable the development of biologically sound interventions aimed at maintaining and/or improving immune system development and preventing disease.
Introduction
Recent advances in immune-mediated disease research have provided a considerable body of proof revealing the importance of the early gut microbiome for neonatal immune system development and disease pathogenesis [see Ref. (1) for a review]. The drastic increase of allergies and other immune-mediated diseases in industrialized countries has been hypothesized to be a result of deficiencies in the exposure to microbial organisms and their products, resulting in impaired immune system development, a concept first introduced as the hygiene hypothesis (2, 3). Pioneer work has identified the first 6 months after birth as a “window of opportunity” (4–7) during which contact with specific microbe-associated molecular patterns (MAMPs) triggers a cascade of reactions crucial for infant gut maturation (8–10). Disrupting early gut community succession may lead to dysbiosis, a state of ecological imbalance ensuing when the community loses key taxa, diversity, and/or metabolic capacity. This state can lead to a reduction of colonization resistance, allowing for a subsequent bloom in opportunistic pathogens [(11); for a definition of relevant ecological concepts refer to Table 1]. Concomitantly, microbial dysbiosis during infancy may also lead to health-related consequences in the neonatal stage or later in life. Preterm neonates can develop necrotizing colitis (NEC), a life-threatening disease strongly associated with microbial dysbiosis (12). Infants may also experience an elevated risk of developing inflammatory diseases such as asthma and allergies (13, 14), type 1 diabetes (15, 16), celiac disease (17), inflammatory bowel disease (18, 19), and obesity (20, 21) when exposed to a microbial dysbiosis early in life. Thus, studying the patterns of microbiome assembly and how disturbances to this process reflect in the developing immune system is of utmost importance to understand the origin of human diseases responsible for enormous health and economic burden to societies.
Table 1. Definition of selected ecological concepts.
The infant gut microbiome is a complex ecosystem involving a great number and diversity of members (e.g. bacteria, phages, fungi, viruses, protozoans) that interact in a spatially and temporally structured environment (26–28). The neonatal gut microbiota can be considered a complex adaptive system in which both low-level local interactions and selection mechanisms combine to create high-level patterns (22). Complex adaptive systems are non-linear (output not proportional to the input, thus impeding predictability) in that they are heavily influenced by stochastic temporal events that result in a plethora of variable outcomes (22). The infant gut microbiome supports a set of emergent properties contributing to host physiology, including nervous, metabolic, and immune development (29–31), as well as tissue differentiation (32, 33). The emergent properties of a complex adaptive system are considered to be supported by combinations of taxonomic and/or functional diversity, as well as key taxonomic and/or functional groups, both of which insure community resilience (22), and increase the difficulty of attributing a cause–effect relationship to unique features or groups. Therefore, including community ecology theory to study the temporal dynamics of the infant gut microbiome has the potential to provide key information about its influence on the host immune system maturation.
Until 2 years of age, the human infant microbiome remains highly heterogeneous and lacks stability (34), being influenced by temporally structured environmental factors such as (1) maternal factors (35–37), (2) birth (38–41), (3) neonatal nutrition (27, 42, 43), and (4) other non-temporally structured factors, such as antibiotic treatments (41, 44, 45). The initial intestinal bacterial community composition of vaginally born infants involves higher levels of a multitude of bacterial groups (e.g., Atopobium, Bacteroides, Clostridium, Escherichia coli, Streptococcus spp. and Prevotella), while the community of infants born by C-section is dominated by skin-related taxa including Staphylococcus spp. (38). Key bacterial groups are also transferred to the infant by breastfeeding: Bifidobacterium and Lactobacillus (46–48). The multiple studies that have shown how intestinal dysbiosis can lead to detrimental immune-mediated outcomes (e.g., asthma, allergies, NEC, etc.) [see Ref. (30) for a review] suggest that the human immune system relies on an evolutionary conserved temporally structured succession of microbiome assembly. Unraveling the links between the temporal mosaics of the gut microbiome (structured succession patterns) with the emergent properties of this ecosystem (e.g., taxonomic and functional diversity, resilience, etc.) is key to improve our understanding of the importance of the infant microbiome for the development of the immune system.
The successful identification of the mechanisms linking the infant gut microbiome and immune development depends on our capacity to disentangle the relative effects of multiple factors (host genetics, environmental factors), key actors (e.g., Bacteroidetes, Bifidobacterium, etc.) and their interactions. Resilience, the ability of a system to adjust its activity to retain its basic functionality after a disturbance, is a crucial property of complex adaptive systems (49) and could be a key characteristic protecting the infant gut microbiome from reaching a dysbiotic state. Here, we review the recent findings on the links between infant gut microbiota and immune system maturation. Our review highlights the reliance of the neonate immune system development on a complex set of host-specific, environmental, temporal, and self-organizing characteristics of the infant gut microbiome. We propose that future studies should consider multi-level dynamics of the infant gut microbial community by disentangling the ecosystem reliance on (1) temporally structured patterns of alpha- and beta-diversity, both taxonomic and functional; (2) keystone species or microbial groups; and (3) inter-kingdom interactions. This will require a conceptual framework based on the understanding that the infant gut harbors a complex and diverse set of microbial species interacting in a temporally structured, multi-level, and non-linear network. Rightfully recognizing these structural characteristics has the potential to enable the identification of disturbance thresholds threatening the healthy development of the infant gut microbiome and its role in immune system training.
Age-Dependent Immune System Development
Multiple studies and comprehensive reviews discuss how the maturation of the immune system relies on the exposure to MAMPs (50–52). Here, we discuss the recent findings demonstrating that the efficiency of microbial exposure in immune system training can be age dependent, suggesting the importance of microbial composition and infant gut microbiome temporal succession patterns.
The gastrointestinal tract is already anatomically and functionally developed at birth in full-term infants, yet important aspects of its maturation occur postnatally and depend on exogenous stimulations with microbial cells, metabolites, hormones, growth factors, and antigens (53, 54). Recent studies in murine models have revealed that several aspects of immune development are more permissive to microbial-mediated changes during early life, and that certain microbial taxa are crucial in these interactions. For instance, oral administration of Bifidobacterium breve was effective in inducing proliferation of FoxP3-positive regulatory T cells (FoxP3+ Tregs) only if administered during the pre-weaning stage in mice (55). This age-dependent promotion of an important tolerogenic immune cell was also shown to be species specific, thereby suggesting that the tolerogenic gut immune response may have adapted to respond to specific—and important—bacterial taxa. Bifidobacterium species and subspecies are dominant members of the infant gut microbiome (56) and are strong modulators of the immune response (57). Their role as keystone taxa of the infant gut is proposed later in this review. Another microbial species that cause an age-dependent immune effect is the Helicobacter pylori, which ameliorated airway hyperresponsiveness more effectively when administered before weaning in two relevant mouse models (58), although it remains unclear if and when this bacterium colonizes the infant gastrointestinal tract.
While age-dependent modulation of the host’s immune response can be attributed to specific microbial taxa, most studies point to global changes in the microbial community (diversity shifts, and metabolites of poly-microbial origin) as drivers of immune development. Cahenzli et al. (59) showed that regulation of IgE responses and amelioration of antigen-induced oral anaphylaxis is dependent upon increased microbial diversity during early life. Their work thus suggests that there may be a diversity threshold necessary for proper maturation of these Th2 immune mechanisms. Furthermore, several other studies have demonstrated the immune consequences of the disruption of the early-life gut microbial community using antibiotics. Antibiotics induce drastic compositional and diversity shifts that lead to changes in crucial immune functions, including Treg proliferation (60, 61), IgE response (60, 62), Th-17 response (61, 63), and basophil-mediated Th2-cell responses (62). Given the influence exerted by these immune functions on widespread tissues and systems, it is not surprising that antibiotic-induced immune alterations during early life in animal models aggravate autoimmune diabetes (61, 64), allergic lung inflammation (60, 62, 63), inflammatory chronic colitis (65), and obesity (20, 21).
Early-life immune development is also reliant on the actions of a group of bacterial metabolites known as short-chain fatty acids (SCFAs). These compounds are direct by-products of bacterial colonic fermentation and are produced at very high rates (66). Acetate, propionate, and butyrate are the SCFAs produced in highest concentrations in the human gut, and are rapidly taken up by the gut epithelium through passive and active transport mechanisms (67). SCFAs are essential energy sources for colonocytes cells in the mammalian gut, and are precursors for gluconeogenesis, liponeogenesis, and protein and cholesterol synthesis (68). Among many of their immune functions [reviewed in Ref. (66)], SCFAs have been shown to induce extrathymic proliferation of Foxp3+ T cells (68–70), which orchestrate peripheral tolerance in mucosal tissues. This critical immune function of SCFA has been shown to be relevant for the offspring even if exposure occurred before birth. Oral administration of acetate during pregnancy was sufficient for the priming of FoxP3+ Treg cells and preventing allergic airway inflammation in the adult offspring (36), suggesting that in utero exposure to maternal gut microbial metabolites contributes to the development of immune functions in the airways of the offspring.
In addition to interactions with the developing immune system, a recent study by Kim et al. (71) suggests that the early gut microbiome confers colonization resistance through the production of bacterial metabolites resulting from age-dependent colonization with key bacterial taxa. Clostridial species from Clostridium clusters IV and XIVa, which increase in abundance with age, induced colonization resistance to intestinal mouse pathogens Salmonella enterica subsp. typhimurium and Citrobacter rodentium. Interestingly, the conferred mechanism of resistance is unrelated to immune adaptors MyD88 and TRIF, and independent of B and T cell function. The settlement of Clostridia in the gut of GF mice was also greatly reduced by the absence of neonatal bacteria, which may help explain the increased susceptibility of newborns and young infants to these GI infections.
Collectively, these studies constitute compelling evidence that key taxa, microbial community diversity, and bacterial metabolites constitute modulatory triggers of host immune function maturation. Although considerable research effort has been made, a great deal of the age-dependent processes through which microbial exposure drives immune system development remains to be identified. The infant gut microbiome temporal succession patterns, driven by birth, weaning, and introduction of solid foods, match marked changes in host immune function (72, 73). Therefore, future studies designed during these events, such as human longitudinal cohorts, hold great potential to improve our understanding of the dynamics at play.
Temporally Structured Environmental Factors
Succession in ecology is defined as the pattern of changes in a community after a disturbance or after the opening of a new patch to colonization (74). Correspondingly, succession in the infant gut microbiome starts with the arrival of pioneer species that transform the gut habitat and enable the settlement of first succession species. The identity of the infant gut pioneer and first succession species is influenced by factors such as maternal factors (e.g., body weight and stress) (35–37), delivery mode (38–41), and type of milk consumption [(27, 42); Figure 1]. The temporal structure of these environmental factors contributes to the identity and dynamics of the infant gut microbiome and plays a role in the immune system training.
Figure 1. Influence of temporal succession events and environmental factors on the infant gut bacterial microbiome. Only the most important differences in bacterial composition are included for each variable, and the size of the circle is proportional to the relative abundance of the bacterial taxa.
Prenatal Life
Even before birth, fetal immune development relies on microbial products present in the placenta. In an experimental system in which germ-free mice were transiently colonized with genetically engineered E. coli HA107, maternal gut colonization influenced the offspring’s immune system by increasing the intestinal group 3 innate lymphoid cells and F4/80+CD11c+ mononuclear cells (iMNCs), and strongly altering the offspring’s intestinal transcriptional profiles (37). These early shifts in the offspring immune system improved the capacity of the pups to avoid inflammatory responses to MAMPs and intestinal microbes’ penetration, thus suggesting that microbial training of the immune system starts in utero (37). Despite some reports suggesting that fetal colonization may begin in utero (75, 76), lack of appropriate contamination controls and failure to show bacterial viability in these studies yields this work inconclusive and inadequate to disproof the currently accepted view of the placenta as a sterile environment (77). More importantly, several studies have shown that early colonization of the infant gut is strongly driven by mode of birth (39–41, 78), thus suggesting that direct colonization of the infant gut most likely begins after membrane rupture, during labor and birth. For example, Backhed et al. (39, 40) showed that the gut microbiome of vaginally born infants exhibited an enrichment in Bifidobacterium, Bacteroides, Escherichia, and Parabacteroides. In comparison, the gut microbiome of infants born through cesarean sections (C-sections) was enriched in microbes associated with the skin, the mouth, and the surrounding environment.
Birth
The infant’s gut habitat changes rapidly after birth with facultative anaerobes species (e.g., E. coli, Staphylococcus, and Streptococcus) colonizing first and consuming the available oxygen (79). A longitudinal study following 39 infants from birth demonstrated that mode of delivery impacts Bacteroides populations in the infant’s gut microbiota between 6 and 18 months of age (41). Yassour et al. (41) showed that, in comparison with vaginal-birth, most infants born by C-section lacked the presence of the Bacteroides genus until about 6–18 months of age. Their work also showed that a higher abundance of Bifidobacterium species, both in C-section and vaginally delivered infants, was detected concomitantly with a lower abundance of Bacteroides, suggesting that infant gut microbial communities are also influenced by microbe–microbe interactions. Delayed colonization with Bacteroides species was also associated with cesarean sections in a study of 24 infants (80), a finding that was linked to lower levels of Th-1-associated chemokines CXCL10 and CXCL11 in blood. Bacteroides species are important and extremely common members of the human gut microbiome, capable of fermenting a variety of fibers in the colon (81) and modulating the immune system (their potential as a keystone taxa and role in immunomodulation is discussed later in this review). Hence, vertical transmission during vaginal birth is likely a structured environmental factor that promotes colonization by members of this influential bacterial group.
Gut microbiome differences driven by mode of birth have been reported in almost all microbiome infant studies that recorded this variable (28, 38, 82–87). Although the cumulated evidence points to the mode of birth being a major influence in the gut pioneer microbiome, one recent study performed on 115 infants showed no differences in the meconium microbial communities between both mode of birth (C-section and vaginal delivery) (88). Unfortunately, key bio-statistical parameters of their analyses are missing from the paper, crucial information to assess the robustness of their results. What still remains unclear is how long these differences last, with only a few reports showing differences beyond early childhood (82). Nonetheless, changes in important microbial groups, community diversity, or functions during this critical and permissive window of immune development are likely to induce immune alterations that may remain beyond the age at which these taxonomic differences are no longer detectable.
Intriguingly, the taxonomic identity of pioneer colonizers not only depends on birth but also on gestational age. A 1-month longitudinal study of 58 preterm infants in a neonatal intensive care unit showed that time post-conception can also impact the type of early colonizers in the premature gut yet not the pattern of bacterial succession (89). Members of the Bacilli class appear as the initial colonizers in premature infants, which contrasts with the initial colonization with Enterobacteriaceae members in most term babies (Figure 1). In addition, this study showed that gut microbiome follows a progression strongly determined by host biology factors, suggesting that, during the first month after delivery, the genetic and physiologic characteristics of the preterm infant gut drive a conserved pattern of succession in gut microbiome.
Milk Consumption
In addition to mode of birth and post-conceptional age, diet during early infancy strongly impacts community structure and diversity. Comparisons between breastfed and formula-fed infants have shown that Bifidobacterium spp. and Lactobacillus spp. predominate in breastfed infants whereas formula-fed infants exhibit higher proportions of Bacteroides spp., Clostridium spp., Streptococcus spp., Enterobacter spp., Citrobacter spp., and Veillonella spp. (39, 40, 90–93). Breast milk can modulate the infant gut microbiome through different mechanisms. First, human breast milk contains a significant number of bacteria that is passed to the infant constantly during the first months of life (46, 47, 94–98). Besides being a direct source of microbes, human milk contains a group of unconjugated glycan resistant to human enzymatic digestion known as human milk oligosaccharides (HMOs). These compounds act as prebiotics for key infant gut taxonomic bacterial groups including Bifidobacterium (99–103) and Bacteroides species (104). Importantly, fermentation of HMOs results in the production of SCFAs (102, 103), increases secretory immunoglobulin A (sIgA) production, and improves gut microbiome resistance to pathogens (105, 106).
Breastfeeding also influences the training of the infant immune system through the presence of antimicrobial compounds in the human milk (lactoferrin, lysozyme) and immune effectors [sIgA, immune cells, and cytokines; (107)]. Bridgman et al. (108) demonstrated that sIgA abundance is associated with breastfeeding status in a cohort of 47 4-month-old infants. sIgA is critical for the infant gut mucosal immune defense [see Ref. (109) for a review] mainly through a process known as immune exclusion, where sIgA adheres to bacterial cells and antigens and prevents their access to the gut epithelium (110). Although this antibody is initially acquired through breastfeeding, the infant gut microbiota will ultimately stimulate its local production through the maturation of B cells (111). Notably, the risk of developing atopy is increased if B cells maturation is delayed (112–115), stressing the importance of breastfeeding in infant gut microbiome and immune development.
Solid Food Introduction and Weaning
The introduction of solid foods constitutes the last step in early-life microbiome succession events, which leads to the consolidation of a gut microbial community that remains largely stable for the remainder of childhood and adult life. Due to the availability of new fiber sources and other substrates, transition to solid foods results in an increase of diversity and the enrichment of Bacteroides spp., Clostridium spp., Ruminococcus spp., Faecalibacterium spp., Roseburia spp., and Anaerostipes spp., as well as the reduction in Bifidobacterium spp. and Enterobacteriaceae (39, 40, 116, 117). Functionally, solid food introduction increases SCFA production, vitamin biosynthesis, and xenobiotic degradation (34, 39, 40). Notably, these changes coincide with important aspects of digestive development (e.g., pancreatic function and intestinal nutrient absorption) and shifts in immune development, some of which are driven by microbes. For instance, the expression of the epithelial antimicrobial granule protein, Angiogenin-4 (Ang4), and of epithelial fucosylated glycans is markedly increased during weaning in conventional but not in germ-free mice. Remarkably, colonization with Bacteroides thetaiotaomicron, a bacterial commensal that increases in abundance post-weaning, was able to induce both Ang4 expression and fucosylated glycan reprogramming [Ang4; (118, 119)], strongly suggesting that specific host functions have adapted to rely on microbial signals that arrive in a temporally structured manner.
Furthermore, it has been suggested that cessation of breastfeeding, rather than solid food introduction, drives the main compositional shifts that result in an “adult-like” gut microbiome. In a longitudinal study of 98 infants, an early weaning age (under 12 months) was associated with an increase in Bacteroides spp., Bilophila spp., Roseburia spp., Clostridium spp., and Anaerostipes spp. In comparison, breastmilk supplementation beyond this age favored a more “immature” community composition, characterized by Bifidobacterium spp., Lactobacillus spp., Collinsella spp., Megasphaera spp., and Veillonella spp. (39, 40).
Infant Gut Community Diversity: An Indicator of Health?
The impact of early-life dysbiosis on the risk of developing several human diseases has led to the hypothesis that there is a critical window during which changes in the gut microbiome are most influential in immune development. During this “window of opportunity,” the infant gut harbors a highly variable and increasingly diverse microbial community of low resilience, which renders it easily disrupted by disturbances such as antibiotic treatments (41). During this period of time, a loss of diversity or change in community composition has the potential to disrupt the development of certain aspects of neonate immune system and to promote a bloom of pathogens, thus increasing the risk of developing immune-mediated and infectious diseases. However, it remains unclear if community diversity per se represents a robust indicator of infant gut microbiome disruption, especially since (1) there could a threshold to be crossed for the gut ecosystem to suffer a significant loss of function; and (2) diversity as a diagnostic tool provides no information on the gut microbial community composition or functional properties.
Many studies have argued that a loss of community diversity could indicate a disruption of the natural infant gut microbiome community. After birth, both the taxonomic and functional diversity of the infant bacterial microbiome have been shown to increase (88). Life-threatening diseases such as NEC have been suggested to occur as an effect of disruption of the natural succession in the infant gut microbiome after antibiotic treatment (120, 121), lowering community diversity and creating an opportunity for other bacterial groups (e.g., Gammaproteobacteria) to dominate the normal bacterial community (122, 123). At that stage, a loss of community diversity can also hinder the training of the immune system by reducing its ability to recognize commensal bacteria [see Ref. (52) for a review]. Recent studies have confirmed that a significant loss in gut microbial diversity is indicative of an increased risk of developing autoimmune diseases (80, 124). In addition, a loss of diversity can promote a long-term increase in IgE levels, which has been suggested to trigger immune-mediated disorders in mice (59).
However, it remains to be determined if the link between the development of immune diseases and the loss of microbial diversity is caused by a reduction of microbial species alone or, more precisely, by a loss of key taxonomic or functional microbial groups essential to the development of the infant immune system. The work of Arrieta et al. (13) on 319 infants in a longitudinal cohort, showed no significant relationship between fecal microbial alpha-diversity and the risk of developing asthma. Yet, four bacterial taxa (Faecalibacterium, Lachnospira, Rothia, and Veillonella), fecal acetate and deconjugated bile acids were significantly altered in babies at risk of asthma. By contrast, Kostic et al. (15) identified that a significant reduction in infant gut community alpha-diversity is a characteristic condition of the T1D state in a cohort of 33 infants predisposed to type 1 diabetes. This loss in alpha-diversity was combined with an alteration of the metabolic pathways and microbial community phylogenetic structure (15). These studies suggest that both subtle and global changes in community composition may lead to immune impairment and disease development, and that functional dysbiosis can occur independently of significant changes in community alpha-diversity.
Community alpha-diversity may also not be a reliable indicator across all human populations given its geographic variability (27). In a study comparing European to Burkina Faso children, De Filippo et al. (125) showed that the latter group had a greater gut microbial diversity and shift in community composition, potentially associated with their high fiber diet. However, other lifestyle factors and environmental exposures may also explain these differences. In addition, bacterial alpha-diversity fluctuates significantly during the first year of life, making it an unreliable ecosystem measurement unless studies are strictly age- and population matched. Further, an opposite relationship between alpha-diversity and health status occurs during the first weeks of life, where lower alpha-diversity and a predominance of a few subspecies of Bifidobacterium longum is associated with better growth (126).
Another factor that is rarely taken into account when assessing microbiome alpha-diversity is the impact of other non-bacterial microbes. In a unique study targeting both infant gut bacterial and fungal communities, Fujimura et al. (14) showed that infant gut bacterial alpha-diversity increased with time while the fungal alpha-diversity decreased in reciprocal correlation. This finding suggests that microbial diversity per se might naturally fluctuate depending on the targeted organism and that currently unexplored inter-kingdom gut microbial associations may influence these dynamics. Most interestingly, their work demonstrated that the fungal beta-diversity better predicted atopy risk than bacterial beta-diversity. Therefore, fluctuations in infant gut fungal community composition could play a role in influencing infant’s susceptibility to childhood allergies and asthma.
The increase in both taxonomic and functional diversity of the infant bacterial gut microbiome in the few months after birth appears to be associated with multiple aspects of the immune system development, providing further evidence that the immune system relies on a temporally structured succession of the gut microbiome. However, the infant gut microbial diversity per se might not be an indicator conveying enough information to be considered as a diagnostic tool. Notwithstanding, studies to date do suggest that the training of the immune system relies on a particular pattern of microbial diversity increasing from birth until 3 years old, and that disrupting this pattern can increase the risk of developing immune-mediated disorders. Future research disentangling the relative impact of species richness, community taxonomic, and functional composition on the retention of infant gut ecosystem emergent properties (e.g., infant immune system development) will provide key information for the development of diagnostic tools.
Keystone Groups
In community ecology, the concept of a keystone species or group of species is described as an actor of a community that is so important to its organization and diversity that losing it provokes a massive cascade of extinctions and loss of ecosystem function (23, 24, 127). In other words, a keystone species has a remarkable impact in relation to its abundance (128). In an ecosystem, keystone species can belong to any trophic levels, from low-level species providing the resources on which a plethora of other species depends, to high-level species applying top-down regulation on the community. Keystone taxa of the infant gut microbiome contribute significantly to the ecosystem by (1) contributing to the establishment of other species; (2) by producing important metabolites including SCFAs (e.g., butyrate) that trigger local trophic cascades; (3) by improving ecosystem resistance against invading pathogenic species; and (4) by aiding in sustaining a balanced symbiosis with the host, which will in turn favor the stability of the microbial ecosystem. Because of the high inter-individual [i.e., Ref. (7)] and temporal (27, 34, 39, 40) variability of the infant gut ecosystem, identifying keystone taxa is a great challenge. Here, we discuss the potential for Bifidobacterium and Bacteroides to be keystone taxa and their role on infant immune system training.
Bifidobacterium
Bifidobacteria are dominant members of the infant gut microbiome, have a large repertoire of genes for the digestion of HMOs (104, 129), and have been isolated from maternal feces, human milk, and infant feces (130, 131), demonstrating how well adapted they are to the transmission routes and growth conditions in the infant gut. B. longum is the predominant species in the human gut, but several B. longum subspecies have different levels of adaptability and functionality in the infant gut. B. longum subsp. infantis (Bifidobacterium infantis), B. longum subsp. longum (B. longum), and B. longum subsp. breve (B. breve) are commonly isolated from healthy breastfed infant feces, while formula-fed infants are also colonized with Bifidobacterium adolescentis (132–134). Of these subspecies, B. infantis has the largest gene repertoire to digest all HMO structures in human milk (129). In addition, when administered as a probiotic to preterm neonates, B. infantis colonizes better than other subspecies (135), which may explain why clinical trials using B. lactis or B. breve as a probiotic strain in the prevention of NEC have been unsuccessful (136, 137), while 5 out of 6 trials using B. infantis have shown to be effective in decreasing NEC incidence in neonates (138–143).
Bifidobacterium species decrease the intestinal luminal pH through the production of lactate and acetate, which is considered a crucial strategy in increasing intestinal nutrient absorption (144). Acetate accounts for more than 80% of the SCFA production in the infant gut (13) [compared to over 50% in the adult gut (145)] and is a key metabolite in the early establishment of colonization resistance, by preventing infections with enteropathogens (146, 147).
Through a process known as metabolic cross-feeding, where the metabolic products of a species or group of species provide growth substrates for other populations, Bifidobacterium’s production of lactate and acetate sustains the growth of other species, such as Roseburia, Eubacterium, Faecalibacterium, and Anaeroestipes (148–151). In addition to this strong influence of microbe–microbe interactions, the sustained growth of other microbial species also enables the subsequent production of butyrate (152, 153). Notably, the lower abundance of colonization with Bifidobacterium in formula-fed babies is associated with a lower concentration of lactate and a higher gut luminal pH compared to breastfed babies (93, 154), and likely accounts for one of the root causes of the striking microbiome discrepancies observed between breastfed and formula-fed infants.
Bifidobacteria also play an exceptionally important role through its direct interactions with the developing immune system. Besides preventing enteropathogenic infections, Bifidobacterium species also protect the infant gut by modulating mucosal barrier function and promoting immunological and inflammatory responses (155, 156). The dominance of the infant gut microbiome by Bifidobacterium spp. was associated with an improved T-cell-mediated response to oral and parenteral vaccines and with lower neutrophilia at 15 weeks of age (126). B. breve has also evolved a mechanism to be protected from the immune system response by synthesizing a specific exopolysaccharide that increases its competitive power for space and colonization in the mouse gut (157, 158).
Collectively, Bifidobacterium species possess important strategies that insure their colonization at high abundance in the infant gut, prevent the growth of competing species that disfavor host fitness, and promote immune development. Due to the very high microbial inter-individual variation, and the number of subspecies found in the infant gut, it remains unclear if Bifidobacterium is a biomarker of infant gut health, yet the sub-species B. infantis may be a likely candidate.
Bacteroides
Together with Bifidobacterium, Bacteroides are the only groups known to use HMOs as a primary nutrient source (102, 103, 159). In addition, Bacteroides species are considered generalists—organisms with a great capacity to switch dietary nutrient sources or host-derived substrates (151). In an elegant study that followed the transcriptional profile of the human and murine symbiont, B. thetaiotaomicron, and the structure of murine cecal glycans, it was demonstrated that this bacterium has the gene encoding capacity to switch from digesting food sugars to foraging host mucus glycans (160). The metabolic plasticity of this species likely improves their adaptability to the fluctuating luminal conditions of the developing infant gut, especially after weaning and introduction of solid foods. Importantly, colonization with Bacteroides species is heavily reliant on natural events that drive succession patterns, such as vaginal birth and breastfeeding (41, 80), suggesting that Bacteroides spp. transmission is advantageous for both the host and members of this taxa, and that it is highly coevolved.
Certain symbionts are thought to have evolved mechanisms through which they influence the host immune system maturation in a way that is beneficial for them. An example of these mechanisms is the development of specific metabolic capacity by B. thetaiotaomicron (119), a microbial species previously linked with angiogenesis in the postnatal intestine development (161). This species influences the gut microbial community by regulating the epithelial glycan synthesis (162), therefore creating a specific niche for itself and for other microorganisms with similar nutrient biochemical capacity.
Another species involved in immune system development is Bacteroides fragilis. Its production of polysaccharide A has been shown to suppress inflammation by downregulating interleukin (IL)-17 (163). Monocolonization of germ-free mice by B. fragilis has been shown to balance Th1 and Th2 responses (164). In addition, these monocolonized mice showed an increase in the conversion of CD4+ T cells into IL-10-producing Foxp3+ Treg cells, which induced a strong anti-inflammatory effect during gut inflammation (165). B. fragilis was also demonstrated to be negatively associated with the expression of toll-like receptor-4 and with lipopolysaccharide (LPS)-induced production of multiple inflammatory cytokines and chemokines (166).
Intriguingly, recent findings on the links between Bacteroides and immune system training suggest that, although they are important members of the early gut microbiome, an overabundance of Bacteroides spp. and a corresponding increase of exposure to their LPS, result in improper stimulation of the innate immune system and in inhibition of LPS tolerance in non-obese diabetic mice. This mechanism was proposed to explain the disparity in type 1 diabetes incidence in Northern Europe, where Russian children have reduced Bacteroides spp. abundance and lower disease rates, compared to Finnish and Estonian children (16). This study highlights the importance of attaining a balanced stimulation of the immune response early in life and how specific gut microbes have evolved to do so in a temporally structured manner. It also underlines the complexity of disentangling the effects of particular bacterial species and higher phylogenetic groups on the emergent properties of the infant gut ecosystem and host fitness.
Future Research
At its beginning, complexity theory suggested that ecosystems exhibiting a higher complexity were more stable when sustaining disturbances such as species loss (167, 168). However, mathematical model simulations of food webs led to the proposal that instead of focusing on the stability of individual populations within an ecosystem, a better comprehension of complex systems could be gained from studying emergent properties such as productivity, resilience, and biomass (169, 170). From this point, studies have employed multiple properties to characterize ecosystems including species richness, taxonomic composition, functional profile, the level of interactions between species of the ecosystem, and the strength of these interactions. This transition in community ecology theory mirrors the improvement of our comprehension of complex ecosystems shifting from a singular to a multi-level perspective.
In this review, we advocate that the infant gut microbiome should be considered as a complex adaptive system crucial to the maintenance of various emergent properties (e.g., infant immune system training). These ecosystem properties are hardly attributable to a single group, instead they seem to rely on a temporally structured pattern of bacterial diversity increase after birth and the succession of particular keystone groups. The properties of complex adaptive systems highlight the great challenges faced by studies of the infant gut microbiome: a system far-from equilibrium dynamics, characterized by permanent novelty and incessant adaptation, dispersed multi-level interactions, and the absence of a global controller (171). The emergent properties of this ecosystem highlight the necessity of prospective, longitudinal infant gut microbiome studies, both taxonomic and functional, which will eventually allow us to identify the critical points at which this system loses its emergent properties and reaches a state of dysbiosis, impeding adequate immune system development. In addition, there is a need to disentangle the influence of loss of taxonomic and functional diversity, as well as of shifts in keystone taxa on immune system training and subsequent disease development. From past studies, we now understand that the maturation of the immune system relies on a temporally structured dynamic, starting in utero with maternal effects, influenced by environmental factors (delivery mode, type of milk consumption, and solid foods) and host biology, and depending heavily on auto-correlated local interactions between microbial groups. Further understanding of this complex adaptive system will also require (1) sampling a variety of geographically distinct human populations, (2) carrying out longitudinal cohorts that sample numerous times during the first 12 months, and (3) combining amplicon-based surveys with functional assays, such as metagenomics and metabolomics.
Another important influence in gut microbiome composition that remains vastly unexplored is the role of non-bacterial microorganisms. The role of the virome, the collection of viruses colonizing the host, has been previously explored in adult animals. Similarly to the bacteriome, the virome strongly interacts with the host immune system, with both positive and negative consequences for host health [see Ref. (172–174) for reviews]. However, it remains unknown what role the virome has during early-life immune development. Further, fungi, protozoans, and helminths, which are traditionally excluded from culture- and non-culture-based studies, are important and immunomodulatory members of the gut microbiome, albeit in smaller proportions than bacteria. Nonetheless, it was recently shown that fungi species are present at much higher diversity in the first months of life, compared to later months, and that this change in diversity inversely correlates with bacterial diversity [(14); Figure 2]. Future studies directed at exploring inter-kingdom gut microbial associations during early life and how these associations influence the host will provide a more global understanding of the microbial triggers influencing immune system development.
Figure 2. Most abundant bacterial (circles) and fungal (triangles) taxa during the first 6 months of human life. Size of the circle is proportional to the relative abundance of the bacterial taxa.
Eventually, the identification of the critical events and factors that influence microbiome resilience and function will enable the development of effective interventions aimed at maintaining and/or improving immune system development and disease prevention. Although an astounding amount of work has been carried out to understand the reliance of the immune system on the infant gut microbiome, much remains to be elucidated on the particular mechanisms responsible for this training. Improvements in our understanding will arise from continuing multidisciplinary joint efforts between immunologists, microbiologists, clinicians, bioinformaticians, and ecologists.
Author Contributions
M-CA formulated the concept for this review, and IL-L wrote the first draft. Both authors co-wrote and revised the entire review article.
Conflict of Interest Statement
The authors declare that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The authors thank Hypothesis Media for producing the art of Figure 1, as well as Dr. Jens Walter for thoroughly reviewing this work.
Funding
M-CA is funded by grants from the Canadian Institutes of Health Research (CIHR) and by the University of Calgary.
References
1. Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. The intestinal microbiome in early life: health and disease. Front Immunol (2014) 5:427. doi:10.3389/fimmu.2014.00427
2. Strachan DP. Hay fever, hygiene, and household size. BMJ (1989) 299(6710):1259. doi:10.1136/bmj.299.6710.1259
3. Strachan DP. Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’. Thorax (2000) 55(Suppl 1):S2. doi:10.1136/thorax.55.suppl_1.S2
4. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy (2007) 62(11):1223–36. doi:10.1111/j.1398-9995.2007.01462.x
5. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study. Gut (2007) 56(5):661–7. doi:10.1136/gut.2006.100164
6. Russell SL, Finlay BB. The impact of gut microbes in allergic diseases. Curr Opin Gastroenterol (2012) 28(6):563–9. doi:10.1097/MOG.0b013e3283573017
7. Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O’Shea CA, et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET cohort. Microbiome (2017) 5(1):4. doi:10.1186/s40168-016-0213-y
8. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet (1999) 353(9148):196–200. doi:10.1016/S0140-6736(98)05104-6
9. Van Der Velden V, Laan M, Baert M, De Waal Malefyt R, Neijens H, Savelkoul H. Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-γ, IL-4 and IL-10. Clin Exp Allergy (2001) 31(7):997–1006. doi:10.1046/j.1365-2222.2001.01176.x
10. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease—an extended version. J Pediatr Gastroenterol Nutr (2004) 38(4):378–88. doi:10.1097/00005176-200404000-00004
11. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science (2012) 336(6086):1255–62. doi:10.1126/science.1224203
12. Cassir N, Benamar S, Khalil JB, Croce O, Saint-Faust M, Jacquot A, et al. Clostridium butyricum strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates. Clin Infect Dis (2015) 61(7):1107–15. doi:10.1093/cid/civ468
13. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med (2015) 7(307):307ra152. doi:10.1126/scitranslmed.aab2271
14. Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med (2016) 22(10):1187–91. doi:10.1038/nm.4176
15. Kostic AD, Gevers D, Siljander H, Vatanen T, Hyotylainen T, Hamalainen AM, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe (2015) 17(2):260–73. doi:10.1016/j.chom.2015.01.001
16. Vatanen T, Kostic AD, d’Hennezel E, Siljander H, Franzosa EA, Yassour M, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell (2016) 165(6):1551. doi:10.1016/j.cell.2016.05.056
17. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis (2015) 26(1):26191. doi:10.3402/mehd.v26.26191
18. Gevers D, Kugathasan S, Denson LA, ázquez-Baeza YV, Van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe (2014) 15(3):382–92. doi:10.1016/j.chom.2014.02.005
19. Imhann F, Bonder MJ, Vila AV, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut (2016) 65(5):740–8. doi:10.1136/gutjnl-2015-310376
20. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature (2012) 488(7413):621–6. doi:10.1038/nature11400
21. Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell (2014) 158(4):705–21. doi:10.1016/j.cell.2014.05.052
22. Levin SA. Ecosystems and the biosphere as complex adaptive systems. Ecosystems (1998) 1(5):431–6. doi:10.1007/s100219900037
23. Paine RT. Food web complexity and species diversity. Am Nat (1966) 100(910):65–75. doi:10.1086/282400
24. Paine RT. A note on trophic complexity and community stability. Am Nat (1969) 103(929):91–3. doi:10.1086/282586
25. Horn HS. The ecology of secondary succession. Annu Rev Ecol Syst (1974) 5(1):25–37. doi:10.1146/annurev.es.05.110174.000325
26. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol (2011) 9(4):279–90. doi:10.1038/nrmicro2540
27. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature (2012) 486(7402):222–7. doi:10.1038/nature11053
28. Lozupone CA, Stombaugh J, Gonzalez A, Ackermann G, Wendel D, ázquez-Baeza YV, et al. Meta-analyses of studies of the human microbiota. Genome Res (2013) 23(10):1704–14. doi:10.1101/gr.151803.112
29. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science (2012) 336(6086):1268–73. doi:10.1126/science.1223490
30. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science (2016) 352(6285):539–44. doi:10.1126/science.aad9378
31. Gray LE, O’Hely M, Ranganathan S, Sly PD, Vuillermin P. The maternal diet, gut bacteria, and bacterial metabolites during pregnancy influence offspring asthma. Front Immunol (2017) 8:365. doi:10.3389/fimmu.2017.00365
32. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet (2012) 13(4):260–70. doi:10.1038/nrg3182
33. Yu Y, Lu L, Sun J, Petrof EO, Claud EC. Preterm infant gut microbiota affects intestinal epithelial development in a humanized microbiome gnotobiotic mouse model. Am J Physiol Gastrointest Liver Physiol (2016) 311(3):G521–32. doi:10.1152/ajpgi.00022.2016
34. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A (2011) 108(Suppl 1):4578–85. doi:10.1073/pnas.1000081107
35. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr (2012) 96(3):544–51. doi:10.3945/ajcn.112.037382
36. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun (2015) 6:7320. doi:10.1038/ncomms8320
37. Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science (2016) 351(6279):1296–302. doi:10.1126/science.aad2571
38. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 107(26):11971–5. doi:10.1073/pnas.1002601107
39. Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe (2015) 17(5):690–703. doi:10.1016/j.chom.2015.04.004
40. Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe (2015) 17(6):852. doi:10.1016/j.chom.2015.05.012
41. Yassour M, Vatanen T, Siljander H, Hamalainen AM, Harkonen T, Ryhanen SJ, et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med (2016) 8(343):343ra81. doi:10.1126/scitranslmed.aad0917
42. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol (2007) 5(7):e177. doi:10.1371/journal.pbio.0050177
43. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, et al. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science (2011) 332(6032):974–7. doi:10.1126/science.1206095
44. Tanaka S, Kobayashi T, Songjinda P, Tateyama A, Tsubouchi M, Kiyohara C, et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol (2009) 56(1):80–7. doi:10.1111/j.1574-695X.2009.00553.x
45. Zeissig S, Blumberg RS. Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat Immunol (2014) 15(4):307–10. doi:10.1038/ni.2847
46. Martín R, Heilig G, Zoetendal E, Smidt H, Rodríguez J. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol (2007) 103(6):2638–44. doi:10.1111/j.1365-2672.2007.03497.x
47. Martín R, Heilig HG, Zoetendal EG, Jiménez E, Fernández L, Smidt H, et al. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res Microbiol (2007) 158(1):31–7. doi:10.1016/j.resmic.2006.11.004
48. Solís G, de Los Reyes-Gavilan C, Fernández N, Margolles A, Gueimonde M. Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut. Anaerobe (2010) 16(3):307–10. doi:10.1016/j.anaerobe.2010.02.004
49. Gao J, Barzel B, Barabási A-L. Universal resilience patterns in complex networks. Nature (2016) 530(7590):307–12. doi:10.1038/nature16948
50. Horner AA. Toll-like receptor ligands and atopy: a coin with at least two sides. J Allergy Clin Immunol (2006) 117(5):1133–40. doi:10.1016/j.jaci.2006.02.035
51. Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J Allergy ClinImmunol (2007) 119(6):1511. doi:10.1016/j.jaci.2007.04.005
52. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 9(5):313–23. doi:10.1038/nri2515
53. Cummins AG, Thompson FM. Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut (2002) 51(5):748–54. doi:10.1136/gut.51.5.748
54. Forchielli ML, Walker WA. The effect of protective nutrients on mucosal defense in the immature intestine. Acta Paediatr Suppl (2005) 94(449):74–83. doi:10.1080/08035320510043592
55. Lyons A, O’mahony D, O’brien F, MacSharry J, Sheil B, Ceddia M, et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy (2010) 40(5):811–9. doi:10.1111/j.1365-2222.2009.03437.x
56. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, et al. Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 7(5):e36957. doi:10.1371/journal.pone.0036957
57. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr (2001) 73(2 Suppl):444S–50S.
58. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest (2011) 121(8):3088–93. doi:10.1172/JCI45041
59. Cahenzli J, Koller Y, Wyss M, Geuking MB, McCoy KD. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe (2013) 14(5):559–70. doi:10.1016/j.chom.2013.10.004
60. Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep (2012) 13(5):440–7. doi:10.1038/embor.2012.32
61. Livanos AE, Greiner TU, Vangay P, Pathmasiri W, Stewart D, McRitchie S, et al. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol (2016) 1(11):16140. doi:10.1038/nmicrobiol.2016.140
62. Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M, et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med (2012) 18(4):538–46. doi:10.1038/nm.2657
63. Russell SL, Gold MJ, Reynolds LA, Willing BP, Dimitriu P, Thorson L, et al. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. J Allergy Clin Immunol (2015) 135(1):100–9. doi:10.1016/j.jaci.2014.06.027
64. Li J, Yang K, Ju T, Ho T, McKay CA, Gao Y, et al. Early life antibiotic exposure affects pancreatic islet development and metabolic regulation. Sci Rep (2017) 7:41778. doi:10.1038/srep41778
65. Scheer S, Medina TS, Murison A, Taves MD, Antignano F, Chenery A, et al. Early-life antibiotic treatment enhances the pathogenicity of CD4+ T cells during intestinal inflammation. J Leukoc Biol (2017) 101(4):893–900. doi:10.1189/jlb.3MA0716-334RR
66. Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol (2016) 5(4):e73. doi:10.1038/cti.2016.17
67. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science (2012) 336(6086):1262–7. doi:10.1126/science.1223813
68. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (2013) 341(6145):569–73. doi:10.1126/science.1241165
69. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 504(7480):451–5. doi:10.1038/nature12726
70. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 504(7480):446–50. doi:10.1038/nature12721
71. Kim YG, Sakamoto K, Seo SU, Pickard JM, Gillilland MG III, Pudlo NA, et al. Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens. Science (2017) 356(6335):315–9. doi:10.1126/science.aag2029
72. Bomba L, Minuti A, Moisá SJ, Trevisi E, Eufemi E, Lizier M, et al. Gut response induced by weaning in piglet features marked changes in immune and inflammatory response. Funct Integr Genomics (2014) 14(4):657–71. doi:10.1007/s10142-014-0396-x
73. Parigi SM, Eldh M, Larssen P, Gabrielsson S, Villablanca EJ. Breast milk and solid food shaping intestinal immunity. Front Immunol (2015) 6:415. doi:10.3389/fimmu.2015.00415
74. Clements FE. Plant Succession: An Analysis of the Development of Vegetation. Washington: Carnegie Institution of Washington (1916).
75. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med (2014) 6(237):237ra65. doi:10.1126/scitranslmed.3008599
76. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep (2016) 6:23129. doi:10.1038/srep23129
77. Perez-Muñoz ME, Arrieta M-C, Ramer-Tait AE, Walter J. A critical assessment of the sterile womb and in utero colonization hypotheses: implications for research on the pioneer infant microbiome. Microbiome (2017) 5(1):48. doi:10.1186/s40168-017-0268-4
78. Dominguez-Bello MG, Cienfuentes C, Romero R, Garcia P, Gomez I, Mago V, et al. PCR detection of Helicobacter pylori in string-absorbed gastric juice. FEMS Microbiol Lett (2001) 198(1):15–6. doi:10.1111/j.1574-6968.2001.tb10612.x
79. Bezirtzoglou E. The intestinal microflora during the first weeks of life. Anaerobe (1997) 3(2–3):173–7. doi:10.1006/anae.1997.0102
80. Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut (2014) 63(4):559–66. doi:10.1136/gutjnl-2012-303249
81. Chen T, Long W, Zhang C, Liu S, Zhao L, Hamaker B. Fiber utilizing capacity varies with Prevotella versus Bacteroides enterotypes. FASEB J (2016) 30(1 Suppl):683.2.
82. Salminen S, Gibson G, McCartney A, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut (2004) 53(9):1388–9. doi:10.1136/gut.2004.041640
83. Adlerberth I, Lindberg E, Åberg N, Hesselmar B, Saalman R, Strannegård I-L, et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr Res (2006) 59(1):96–101. doi:10.1203/01.pdr.0000191137.12774.b2
84. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics (2006) 118(2):511–21. doi:10.1542/peds.2005-2824
85. Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr (2008) 138(9):1796S–800S.
86. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere M-F. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol (2013) 21(4):167–73. doi:10.1016/j.tim.2012.12.001
87. Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med (2016) 8(343):343ra82. doi:10.1126/scitranslmed.aad7121
88. Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med (2017) 23(3):314–26. doi:10.1038/nm.4272
89. La Rosa PS, Warner BB, Zhou Y, Weinstock GM, Sodergren E, Hall-Moore CM, et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci U S A (2014) 111(34):12522–7. doi:10.1073/pnas.1409497111
90. Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett (2005) 243(1):141–7. doi:10.1016/j.femsle.2004.11.052
91. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr (2009) 98(2):229–38. doi:10.1111/j.1651-2227.2008.01060.x
92. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr (2010) 51(1):77–84. doi:10.1097/MPG.0b013e3181d1b11e
93. Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe (2011) 17(6):478–82. doi:10.1016/j.anaerobe.2011.03.009
94. Heikkilä M, Saris P. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol (2003) 95(3):471–8. doi:10.1046/j.1365-2672.2003.02002.x
95. Gueimonde M, Laitinen K, Salminen S, Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology (2007) 92(1):64–6. doi:10.1159/000100088
96. Collado M, Delgado S, Maldonado A, Rodríguez J. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Lett Appl Microbiol (2009) 48(5):523–8. doi:10.1111/j.1472-765X.2009.02567.x
97. Martín R, Jiménez E, Heilig H, Fernández L, Marín ML, Zoetendal EG, et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol (2009) 75(4):965–9. doi:10.1128/AEM.02063-08
98. Hunt KM, Foster JA, Forney LJ, Schütte UM, Beck DL, Abdo Z, et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One (2011) 6(6):e21313. doi:10.1371/journal.pone.0021313
99. Ward RE, Niaeonuevo M, Mills DA, Lebrilla CB, German JB. Research article in vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res (2007) 51:1398–405. doi:10.1002/mnfr.200700150
100. Sela DA, Mills DA. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol (2010) 18(7):298–307. doi:10.1016/j.tim.2010.03.008
101. Barile D, Rastall RA. Human milk and related oligosaccharides as prebiotics. Curr Opin Biotechnol (2013) 24(2):214–9. doi:10.1016/j.copbio.2013.01.008
102. Yu Z-T, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, et al. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology (2013) 23(2):169–77. doi:10.1093/glycob/cws138
103. Yu ZT, Chen C, Newburg DS. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology (2013) 23(11):1281–92. doi:10.1093/glycob/cwt065
104. Marcobal A, Sonnenburg JL. Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect (2012) 18(Suppl 4):12–5. doi:10.1111/j.1469-0691.2012.03863.x
105. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res (2007) 61(1):2–8. doi:10.1203/01.pdr.0000250274.68571.18
106. Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci (2009) 87(13 Suppl):26–34. doi:10.2527/jas.2008-1347
107. Moles L, Gomez M, Jimenez E, Fernandez L, Bustos G, Chaves F, et al. Preterm infant gut colonization in the neonatal ICU and complete restoration 2 years later. Clin Microbiol Infect (2015) 21(10):936.e1–10. doi:10.1016/j.cmi.2015.06.003
108. Bridgman SL, Konya T, Azad MB, Sears MR, Becker AB, Turvey SE, et al. Infant gut immunity: a preliminary study of IgA associations with breastfeeding. J Dev Orig Health Dis (2016) 7(1):68–72. doi:10.1017/S2040174415007862
109. Brandtzaeg P. Secretory IgA: designed for anti-microbial defense. Front Immunol (2013) 4:222. doi:10.3389/fimmu.2013.00222
110. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol (2009) 70(6):505–15. doi:10.1111/j.1365-3083.2009.02319.x
111. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 303(5664):1662–5. doi:10.1126/science.1091334
112. Kukkonen K, Kuitunen M, Haahtela T, Korpela R, Poussa T, Savilahti E. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol (2010) 21(1 Pt I):67–73. doi:10.1111/j.1399-3038.2009.00907.x
113. Sandin A, Björkstén B, Böttcher MF, Englund E, Jenmalm MC, Bråbäck L. High salivary secretory IgA antibody levels are associated with less late-onset wheezing in IgE-sensitized infants. Pediatr Allergy Immunol (2011) 22(5):477–81. doi:10.1111/j.1399-3038.2010.01106.x
114. Orivuori L, Loss G, Roduit C, Dalphin JC, Depner M, Genuneit J, et al. Soluble immunoglobulin A in breast milk is inversely associated with atopic dermatitis at early age: the PASTURE cohort study. Clin Exp Allergy (2014) 44(1):102–12. doi:10.1111/cea.12199
115. Orivuori L, Mustonen K, de Goffau MC, Hakala S, Paasela M, Roduit C, et al. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin Exp Allergy (2015) 45(5):928–39. doi:10.1111/cea.12522
116. Fallani M, Amarri S, Uusijarvi A, Adam R, Khanna S, Aguilera M, et al. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (2011) 157(5):1385–92. doi:10.1099/mic.0.042143-0
117. Vallès Y, Artacho A, Pascual-García A, Ferrús ML, Gosalbes MJ, Abellán JJ, et al. Microbial succession in the gut: directional trends of taxonomic and functional change in a birth cohort of Spanish infants. PLoS Genet (2014) 10(6):e1004406. doi:10.1371/journal.pgen.1004406
118. Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science (1996) 273(5280):1380. doi:10.1126/science.273.5280.1380
119. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol (2003) 4(3):269–73. doi:10.1038/ni888
120. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics (2009) 123(1):58–66. doi:10.1542/peds.2007-3423
121. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr (2011) 159(3):392–7. doi:10.1016/j.jpeds.2011.02.035
122. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J (2009) 3(8):944–54. doi:10.1038/ismej.2009.37
123. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One (2011) 6(6):e20647. doi:10.1371/journal.pone.0020647
124. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 44(6):842–50. doi:10.1111/cea.12253
125. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 107(33):14691–6. doi:10.1073/pnas.1005963107
126. Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, Raqib R, et al. Stool microbiota and vaccine responses of infants. Pediatrics (2014) 134(2):e362–72. doi:10.1542/peds.2013-3937
127. Mills LS, Soulé ME, Doak DF. The keystone-species concept in ecology and conservation. Bioscience (1993) 43(4):219–24. doi:10.2307/1312122
128. Power ME, Tilman D, Estes JA, Menge BA, Bond WJ, Mills LS, et al. Challenges in the quest for keystones. Bioscience (1996) 46(8):609–20. doi:10.2307/1312990
129. Underwood MA, German JB, Lebrilla CB, Mills DA. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res (2015) 77(1–2):229–35. doi:10.1038/pr.2014.156
130. Jost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr (2013) 110(7):1253–62. doi:10.1017/S0007114513000597
131. Jost T, Lacroix C, Braegger C, Chassard C. Stability of the maternal gut microbiota during late pregnancy and early lactation. Curr Microbiol (2014) 68(4):419–27. doi:10.1007/s00284-013-0491-6
132. Sakata S, Tonooka T, Ishizeki S, Takada M, Sakamoto M, Fukuyama M, et al. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiol Lett (2005) 243(2):417–23. doi:10.1016/j.femsle.2005.01.002
133. Turroni F, Foroni E, Pizzetti P, Giubellini V, Ribbera A, Merusi P, et al. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol (2009) 75(6):1534–45. doi:10.1128/AEM.02216-08
134. Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology (2010) 156(Pt 11):3329–41. doi:10.1099/mic.0.043224-0
135. Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr (2013) 163(6):1585–1591.e9. doi:10.1016/j.jpeds.2013.07.017
136. Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr (2010) 51(2):203–9. doi:10.1097/MPG.0b013e3181dc0d93
137. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR; Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet (2016) 387(10019):649–60. doi:10.1016/S0140-6736(15)01027-2
138. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr (2005) 147(2):192–6. doi:10.1016/j.jpeds.2005.03.054
139. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics (2005) 115(1):1–4. doi:10.1542/peds.2004-1463
140. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr (2009) 55(2):128–31. doi:10.1093/tropej/fmn091
141. Underwood MA, Salzman NH, Bennett SH, Barman M, Mills DA, Marcobal A, et al. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr (2009) 48(2):216–25. doi:10.1097/MPG.0b013e31818de195
142. Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montano-Rodriguez R, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed (2013) 98(1):F5–9. doi:10.1136/archdischild-2011-300435
143. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics (2013) 132(6):1055–62. doi:10.1542/peds.2013-1339
144. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int (2012) 95(1):50–60. doi:10.5740/jaoacint.SGE_Macfarlane
145. Louis P, Scott KP, Duncan SH, Flint HJ. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol (2007) 102(5):1197–208. doi:10.1111/j.1365-2672.2007.03322.x
146. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 469(7331):543–7. doi:10.1038/nature09646
147. Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M. Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes (2012) 3(5):449–54. doi:10.4161/gmic.21214
148. Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol (2004) 70(10):5810–7. doi:10.1128/AEM.70.10.5810-5817.2004
149. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol (2006) 72(5):3593–9. doi:10.1128/AEM.72.5.3593-3599.2006
150. Falony G, Vlachou A, Verbrugghe K, De Vuyst L. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol (2006) 72(12):7835–41. doi:10.1128/AEM.01296-06
151. Flint HJ, Duncan SH, Scott KP, Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc (2015) 74(1):13–22. doi:10.1017/S0029665114001463
152. Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol (2002) 68(10):5186–90. doi:10.1128/AEM.68.10.5186-5190.2002
153. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol (2014) 12(10):661–72. doi:10.1038/nrmicro3344
154. Ogawa K, Ben RA, Pons S, de Paolo MI, Bustos Fernandez L. Volatile fatty acids, lactic acid, and pH in the stools of breast-fed and bottle-fed infants. J Pediatr Gastroenterol Nutr (1992) 15(3):248–52. doi:10.1097/00005176-199210000-00004
155. Butel M-J, Suau A, Campeotto F, Magne F, Aires J, Ferraris L, et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr (2007) 44(5):577–82. doi:10.1097/MPG.0b013e3180406b20
156. Abdulkadir B, Nelson A, Skeath T, Marrs EC, Perry JD, Cummings SP, et al. Routine use of probiotics in preterm infants: longitudinal impact on the microbiome and metabolome. Neonatology (2016) 109(4):239–47. doi:10.1159/000442936
157. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A (2012) 109(6):2108–13. doi:10.1073/pnas.1115621109
158. Fanning S, Hall LJ, van Sinderen D. Bifidobacterium breve UCC2003 surface exopolysaccharide production is a beneficial trait mediating commensal-host interaction through immune modulation and pathogen protection. Gut Microbes (2012) 3(5):420–5. doi:10.4161/gmic.20630
159. Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, Desai P, et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe (2011) 10(5):507–14. doi:10.1016/j.chom.2011.10.007
160. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science (2005) 307(5717):1955–9. doi:10.1126/science.1109051
161. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A (2002) 99(24):15451–5. doi:10.1073/pnas.202604299
162. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science (2001) 292(5519):1115–8. doi:10.1126/science.1058709
163. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 107(27):12204–9. doi:10.1073/pnas.0909122107
164. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 122(1):107–18. doi:10.1016/j.cell.2005.05.007
165. Telesford KM, Yan W, Ochoa-Reparaz J, Pant A, Kircher C, Christy MA, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+ Foxp3+ T cells and Treg function. Gut Microbes (2015) 6(4):234–42. doi:10.1080/19490976.2015.1056973
166. Sjogren YM, Tomicic S, Lundberg A, Bottcher MF, Bjorksten B, verremark-Ekstrom ES, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy (2009) 39(12):1842–51. doi:10.1111/j.1365-2222.2009.03326.x
167. MacArthur R. Fluctuations of animal populations and a measure of community stability. Ecology (1955) 36(3):533–6.
168. Elton CC. The reasons for conservation. The Ecology of Invasions by Animals and Plants. Netherlands, London, UK: Springer; Methuen and Co. (1958). p. 143–53. doi:10.1007/978-94-009-5851-7
169. May RM. Stability and Complexity in Model Ecosystems. Princeton: Princeton University Press (1973).
170. Tilman D. The ecological consequences of changes in biodiversity: a search for general principles. Ecology (1999) 80(5):1455–74. doi:10.2307/176540
171. Arthur WB, Durlauf SN, Lane DA. The Economy As an Evolving Complex System II. Reading, MA: Addison-Wesley (1997).
172. Kernbauer E, Cadwell K. Autophagy, viruses, and intestinal immunity. Curr Opin Gastroenterol (2014) 30(6):539–46. doi:10.1097/MOG.0000000000000121
173. Virgin HW. The virome in mammalian physiology and disease. Cell (2014) 157(1):142–50. doi:10.1016/j.cell.2014.02.032
Keywords: microbiome, early-life events, immune development, microbial ecology, diversity, keystone taxa
Citation: Laforest-Lapointe I and Arrieta M-C (2017) Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological Perspective. Front. Immunol. 8:788. doi: 10.3389/fimmu.2017.00788
Received: 30 April 2017; Accepted: 22 June 2017;
Published: 10 July 2017
Edited by:
Larry J. Dishaw, University of South Florida St. Petersburg, United StatesReviewed by:
Leticia A. Carneiro, Federal University of Rio de Janeiro, BrazilShai Bel, University of Texas Southwestern Medical Center, United States
Copyright: © 2017 Laforest-Lapointe and Arrieta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marie-Claire Arrieta, marie.arrieta@ucalgary.ca